Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_provenance.
- NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_assertion description "[NAT2 slow metabolizers are more prone to the side effects of polymorphically acetylated drugs, as is the SLE-like syndrome induced by hydralazine and procainamide, the side effects due to sulphasalazine and the skin rash secondary to many sulphonamides.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_provenance.
- NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_assertion evidence source_evidence_literature NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_provenance.
- NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_assertion SIO_000772 18680473 NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_provenance.
- NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_assertion wasDerivedFrom befree-20150227 NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_provenance.
- NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_assertion wasGeneratedBy ECO_0000203 NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_provenance.
- befree-20150227 importedOn "2015-02-27" NP217532.RAkrNyh89fo8K_0HCtr5EMyQFlspNv-JFqLADo308Zg3E130_provenance.